Innovation supports revenue growth acceleration in Q3
. - Revenue growth for Q3 accelerated to 5.5% (CER) lifting revenue for the first nine months to EUR 416.7 million (up…
. - Revenue growth for Q3 accelerated to 5.5% (CER) lifting revenue for the first nine months to EUR 416.7 million (up…
. - Umsatzwachstum beschleunigte sich im dritten Quartal auf 5,5% bei konstanten Wechselkursen (kWk), wodurch der Umsat…
. - Revenue for the first quarter of EUR 138.8 million was up 2.8% at constant exchange rates (CER) and down 1.9% in EU…
. - Umsatz im ersten Quartal beläuft sich auf CHF 169,8 Mio. (EUR 138,8 Mio.) und ist damit um 2,8% bei konstanten Währ…
Nobel Biocare introduces its latest innovations in tissue regeneration and treatment planning at the 29th Annual Meeting…
. - Amazing new angulated screw channel concept and tooling must be experienced to be believed - New cost-effective No…
. - Revenue for Q3 was up 4.8% at constant exchange rates (CER) driving year-to-date revenue up 1.6% at CER to EUR 417.…
. - Umsatz im dritten Quartal erhöht sich um 4,8% bei konstanten Wechselkursen (kWk), wodurch sich das Wachstum für das…
. - New NobelProcera® 2G System reduces scanning time up to 50%, increases business opportunities - New 'open access'…
. - Revenue for the second quarter was up 2.3% at constant exchange rates (CER) driving revenue for the first half to E…